Dr. Reddys Laboratories Ltd announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the U.S. Food and Drug Administration (USFDA).
- Read more about Dr. Reddys Laboratories announces the launch of Ertapenem for Injection in the U.S. Market
- Log in or register to post comments
source https://www.pharmatutor.org/content/may-2021/dr.-reddys-laboratories-announces-the-launch-of-ertapenem-for-injection-in-the-us-market
No comments:
Post a Comment